Antiobesity effects of quercetin-rich onion peel extract on the differentiation of 3T3-L1 preadipocytes and the adipogenesis in high fat-fed rats

Food and Chemical Toxicology

Volumn 58, Issue , 2013, Pages 347-354

  Moon, Jiyoung ^a   Do, Hyun Ju ^a   Kim, Oh Yoen ^b   Shin, Min Jeong ^a  

^a Korea University   (South Korea)

^b Dong A University   (South Korea)

Author keywords

3T3 L1; Adipogenesis; Antiobesity; High fat diet; Onion peel extract; Quercetin

Indexed keywords

ACETYL COENZYME A CARBOXYLASE; ACTIVATING PROTEIN 2; CARNITINE PALMITOYLTRANSFERASE; CARNITINE PALMITOYLTRANSFERASE 1ALPHA; CCAAT ENHANCER BINDING PROTEIN ALPHA; FATTY ACID BINDING PROTEIN 4; FATTY ACID SYNTHASE; MESSENGER RNA; ONION EXTRACT; PEPTIDES AND PROTEINS; QUERCETIN; TRIACYLGLYCEROL; UNCLASSIFIED DRUG; UNCOUPLING PROTEIN 1;

ACETYL COA CARBOXYLASE GENE; ACTIVATING PROTEIN 2 GENE; ADIPOGENESIS; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BODY WEIGHT; CARNITINE PALMITOYLTRANSFERASE 1ALPHA GENE; CELL DIFFERENTIATION; CELL STRAIN 3T3; CELL VIABILITY; CONTROLLED STUDY; DOWN REGULATION; DRUG MECHANISM; DRUG SCREENING; EPIDIDYMIS FAT; FATTY ACID BINDING PROTEIN 4 GENE; GENE; LIPID DIET; LIPID STORAGE; MALE; MESENTERIC FAT WEIGHT; MOUSE; NONHUMAN; OBESITY; ONION; ONION PEEL; PROADIPOCYTE; RAT; RETROPERITONEAL FAT WEIGHT; SUPPLEMENTATION; UNCOUPLING PROTEIN 1 GENE; UPREGULATION; WEIGHT;

3T3-L1; ACC; ACETYL-COA CARBOXYLASE; ACTIVATING PROTEIN; ADIPOGENESIS; ANTIOBESITY; AP2; CARNITINE PALMITOYLTRANSFERASE-1 Α; CPT-1Α; FABP4; FAS; FATTY ACID BINDING PROTEIN 4; FATTY ACID SYNTHASE; HIGH-FAT DIET; ONION PEEL EXTRACT; OPE; QUERCETIN;

3T3-L1 CELLS; ADIPOCYTES; ADIPOGENESIS; ANIMALS; ANTI-OBESITY AGENTS; BASE SEQUENCE; CELL DIFFERENTIATION; DIET, HIGH-FAT; DNA PRIMERS; LIPID METABOLISM; MALE; MICE; ONIONS; PLANT EXTRACTS; QUERCETIN; RATS; RATS, SPRAGUE-DAWLEY; REAL-TIME POLYMERASE CHAIN REACTION; RNA, MESSENGER; WEIGHT GAIN;

ALLIUM CEPA; RATTUS;

EID: 84879308297     PISSN: 02786915     EISSN: 18736351     Source Type: Journal    
DOI: 10.1016/j.fct.2013.05.006     Document Type: Article

References (34)

1. Ahn J., Lee H., Kim S., Park J., Ha T. The anti-obesity effect of quercetin is mediated by the AMPK and MAPK signaling pathways. Biochem. Biophys. Res. Commun. 2008, 373:545-549.
2. Bagheri R., Lehrke M., Kapoor S., Wolfe M., Terembula K., et al. Plasma levels of fatty acid binding proteins 4 and 5 are markers of adiposity and the metabolic syndrome but are not independent predictors of subclinical atherosclerosis in type 2 diabetes. Circulation 2007, 116:270.
3. Baxa C.A., Sha R.S., Buelt M.K., Smith A.J., Matarese V., Chinander L.L., Boundy K.L., Bernlohr D.A. Human adipocyte lipid-binding protein: purification of the protein and cloning of its complementary DNA. Biochemistry 1989, 28(22):8683-8690.
4. Brun R.P., Kim J.B., Hu E., Spiegelman B.M. Peroxisome proliferator-activated receptor gamma and the control of adipogenesis. Curr. Opin. Lipidol. 1991, 8:212-218.
5. Chien P.J., Chen Y.C., Lu S.C., Sheu Dietary flavonoids suppress adipogenesis in 3T3-L1preadipocytes. J. Food. Drug. Anal. 2005, 13(2):168-175.
6. Coe N.R., Bernlohr D.A. Physiological properties and functions of intracellular fatty acid-binding proteins. Biochim. Biophys. Acta. 1998, 1391:287-306.
7. de Ferranti S., Mozaffarian D. The perfect storm, obesity, adipocyte dysfunction: and metabolic consequences. Clin. Chem. 2008, 54:945-955.
8. Duarte J., Perez-Palencia R., Vargas F., Ocete M.A., Perez-Vizcaino F., Zarzuelo A., Tamargo J. Antihypertensive effects of the flavonoid quercetin in spontaneously hypertensive rats. Brit. J. Pharmacol. 2001, 133:117-124.
9. Esterbauer H., Schneitler C., Oberkofler H., Ebenbichler C., Paulweber B., Sandhofer F., Ladurner G., Hell E., Strosberg A.D., Patsch J.R., Krempler F., Patsch W.A. Common polymorphism in the promoter of UCP2 is associated with decreased risk of obesity in middle aged humans. Nat. Genet. 2001, 28:178-183.
10. Farmer S.R., Auwerx J. Adipose tissue: new therapeutic targets from molecular and genetic studies: IASO Stock Conference 2003 report. Obes. Rev. 2004, 5:189-196.
11. Fisher R.M., Eriksson P., Hoffstedt J., Hotamisligil G.S., Thörne A. Fatty acid binding protein expression in different adipose tissue depots from lean and obese individuals. Diabetologia 2001, 44(10):1268-1273.
12. Formica J.V., Regelson W. Review of the biology of quercetin and related bioflavonoids. Food. Chem. Toxicol. 1995, 33:1061-1080.
13. Gao X., Li K., Hui X., Kong X., Sweeney G., Wang Y., Xu A., Teng M., Liu P., Wu D. Carnitine palmitoyltransferase 1A prevents fatty acid-induced adipocyte dysfunction through suppression of c-Jun N-terminal kinase. Biochem. J. 2011, 435(3):723-732.
14. Hertog M.G.L., Feskens E.J.M., Hollman P.C.H., Katan M.B., Kromhout D. Dietary antioxidant flavonoids and risk of coronary heart disease: the Zutphen Elderly Study. The Lancet 1993, 342:1007-1011.
15. Hertzel A.V., Bernlohr D.A. The mammalian fatty acid-binding protein multigene family: molecular and genetic insights into function. Trends. Endocrinol. Metab. 2000, 11:175-180.
16. Hilger-Eversheim K., Moser M., Schorle H., Buettner R. Regulatory roles of AP-2 transcription factors in vertebrate development, apoptosis and cell-cycle control. Gene 2002, 260(1-2):1-12.
17. Hossain P., Kawar B., El Nahas M. Obesity and diabetes in the developing world - a growing challenge. New Engl. J. Med. 2007, 356:213-215.
18. Huang B., Yuan H.D., Kim D.Y., Quan H.Y., Chung S.H. Cinnamaldehyde prevents adipocyte differentiation and adipogenesis via regulation of peroxisome proliferator-activated receptor-γ (PPARγ) and AMP-activated protein kinase (AMPK) pathways. J. Agric. Food. Chem. 2011, 59:3666-3673.
19. Hung H. Dietary quercetin inhibits proliferation of lung carcinoma cells. Forum Nutr. 2007, 60:146-157.
20. Kim O.Y., Lee S.M., Do H., Moon J., Lee K.H., Cha Y.J., Shin M.J. Influence of quercetin-rich onion peel extracts on adipokine expression in the visceral adipose tissue of rats. Phytother. Res. 2012, 26(3):432-437.
21. Knekt P., Kumpulainen J., Järvinen R., Rissanen H., Heliövaara M., Reunanen A., Hakulinen T., Aromaa A. Flavonoid intake and risk of chronic diseases. Am. J. Clin. Nutr. 2002, 76:560-568.
22. Kopelman P.G. Obesity as a medical problem. Nature 2000, 404:635-643.
23. Lasa A., Churruca I., Eseberri I., Andrés-Lacueva C., Portillo M.P. Delipidating effect of resveratrol metabolites in 3T3-L1adipocytes. Mol. Nutr. Food. Res. 2012, 56(10):1559-1568.
24. Mink P.J., Scrafford C.G., Barraj L.M., Harnack L., Hong C.P., Nettleton J.A., Jacobs D.R. Flavonoid intake and cardiovascular disease mortality: a prospective study in postmenopausal women. Am. J. Clin. Nutr. 2007, 85:895-909.
25. Makowski L., Hotamisligil G.S. Fatty acid binding proteins-the evolutionary crossroads of inflammatory and metabolic responses. J. Nutr. 2004, 134:2464S-2468S.
26. McGarry J.D., Brown N.F. The mitochondrial carnitine palmitoyltransferase system: from concept to molecular analysis. Eur. J. Biochem. 1997, 244:1-14.
27. Mello M.M., Studdert D.M., Brennan T.A. Obesity - the new frontier of public health law. New Engl. J. Med. 2006, 354:2601-2610.
28. Park H.J., Yang J.Y., Ambati S., Della-Fera M.A., Hausman D.B., Rayalam S., Baile C.A. Combined effects of genistein, quercetin: and resveratrol in human and 3T3-L1 adipocytes. J. Med. Food. 2008, 11:773-783.
29. Queipo-Ortuño M.I., Escoté X., Ceperuelo-Mallafré V., Garrido-Sanchez L., Miranda M., et al. FABP4 Dynamics in obesity: discrepancies in adipose tissue and liver expression regarding circulating plasma levels. PLoS ONE 2012, 7(11):e48605.
30. Ramos F.A., Takaishi Y., Shirotori M., Kawaguchi Y., Tsuchiya K., Shibata H., Higuti T., Tadokoro T., Takeuchi M. Antibacterial and antioxidant activities of quercetin oxidation products from yellow onion (Allium cepa) skin. J. Agric. Food. Chem. 2006, 54:3551-3557.
31. Rosen E.D., MacDougald O.A. Adipocyte differentiation from the inside out. Nat. Rev. Mol. Cell. Biol. 2006, 7:885-896.
32. Sakai Y., Murakami T., Yamamoto Y. Antihypertensive effects of onion on NO synthase inhibitor-induced hypertensive rats and spontaneously hypertensive rats. Biosci. Biotechnol. Biochem. 2003, 67:1305-1311.
33. Tinahones F.J., Garrido-Sanchez L., Miranda M., García-Almeida J.M., Macias-Gonzalez M. Obesity and insulin resistance-related changes in the expression of lipogenic and lipolytic genes in morbidly obese subjects. Obes. Surg. 2010, 20:1559-1567.
34. Yim M.J., Hosokawa M., Mizushina Y., Yoshida H., Saito Y., Miyashita K. Suppressive effects of amarouciaxanthin A on 3T3-L1 adipocyte differentiation through down-regulation of PPARγ and C/EBPα mRNA expression. J. Agric. Food Chem. 2011, 59:1646-1652.